Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.080
+0.030 (2.86%)
At close: Dec 20, 2024, 4:00 PM
1.140
+0.060 (5.56%)
After-hours: Dec 20, 2024, 7:58 PM EST
Dermata Therapeutics Stock Forecast
DRMA's stock price has decreased by -88.92% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for DRMA stock has a target of 6.00, which predicts an increase of 455.56% from the current stock price of 1.08.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 21, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for DRMA is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +455.56% | Aug 21, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $240 → $60 | Strong Buy | Maintains | $240 → $60 | +5,455.56% | Mar 23, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $3,360 | Strong Buy | Initiates | $3,360 | +311,011.11% | Sep 21, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $2,160 | Strong Buy | Initiates | $2,160 | +199,900.00% | Sep 14, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-15.08
from -39.98
EPS Next Year
-3.95
from -15.08
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -15.52 | -4.06 | -1.76 |
| Avg | -15.08 | -3.95 | -1.71 |
| Low | -14.48 | -3.79 | -1.65 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.